| Trial ID: | L0800 |
| Source ID: | NCT03439917
|
| Associated Drug: |
L-Carnitine
|
| Title: |
Effect of Carnitine Supplementation on Liver Steatosis, Insulin Sensitivity, Plasma Glucose Homeostasis, Skeletal Muscle Metabolism and Energetics: a Pilot Study
|
| Acronym: |
ECLIPSE
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease;Insulin Resistance
|
| Interventions: |
Dietary Supplement: L-Carnitine tartrate;Dietary Supplement: Meal Replacement Drink;Dietary Supplement: Maltodextrin
|
| Outcome Measures: |
Intrahepatic triglyceride (IHTG) contentliver sensitivity to insulin;whole body insulin sensitivity;Muscle lipid content;Skeletal muscle sensitivity to insulin;whole body composition;Liver energy metabolism
|
| Sponsor/Collaborators: |
University of Nottingham
|
| Gender: |
Male
|
| Age: |
18 Years50 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
30
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
|
| Start Date: |
14/02/2018
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
13 December 2021
|
| Locations: |
United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT03439917
|
